Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced approval for the latest version of its next-gen
Daniel Bradbury Sells 3,750 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
07:18am, Saturday, 22'nd Aug 2020
Castle Biosciences (NASDAQ:CSTL) Director Daniel Bradbury sold 3,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $43.18, for
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
A Closer Look At Castle Biosciences, Inc.'s (NASDAQ:CSTL) Uninspiring ROE
01:03pm, Tuesday, 11'th Aug 2020
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
10:25pm, Monday, 10'th Aug 2020
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 80.95% and 39.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock
Castle Biosciences Announces Second Quarter 2020 Results
08:05pm, Monday, 10'th Aug 2020
Castle Biosciences today announced its financial results for the second quarter and six months ended June 30, 2020.
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
11:00am, Wednesday, 05'th Aug 2020
Castle Biosciences is scheduled to present a company overview at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020.
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:31pm, Monday, 03'rd Aug 2020
Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castle Biosciences (NASDAQ:CSTL) Expected to Announce Earnings of -$0.42 Per Share
05:12am, Monday, 03'rd Aug 2020
Wall Street brokerages forecast that Castle Biosciences (NASDAQ:CSTL) will report earnings per share of ($0.42) for the current quarter, according to Zacks Investment Research. Two analysts have made
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
11:00am, Monday, 27'th Jul 2020
Castle will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
12:00am, Monday, 27'th Jul 2020
Castle will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.
Castle Biosciences (NASDAQ:CSTL) Reaches New 12-Month High at $45.27
04:38am, Friday, 17'th Jul 2020
Shares of Castle Biosciences (NASDAQ:CSTL) hit a new 52-week high during trading on Wednesday . The stock traded as high as $45.27 and last traded at $44.28, with a volume of 38331 shares changing han
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 16)
AC Immune SA (NASDAQ: ACIU...
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of a multic
